Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) were up 4.9% on Monday . The company traded as high as GBX 1.60 and last traded at GBX 1.60. Approximately 797,842 shares were traded during trading, a decline of 51% from the average session volume of 1,624,836 shares. The stock had previously closed at GBX 1.52.
Cizzle Biotechnology Price Performance
The firm’s 50 day moving average is GBX 2.10 and its 200 day moving average is GBX 2.22. The company has a market cap of £6.66 million, a PE ratio of -9.22 and a beta of 0.02.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Further Reading
- Five stocks we like better than Cizzle Biotechnology
- Photronics Is Quietly Becoming a Key Winner From the AI Boom
- Looking Beyond NVIDIA? These 3 AI ETFs Are Beating the Market
- Palantir’s Kool-Aid Moment: The Math Behind Karp’s Forecast
- OpenAI’s Jalapeño Chip Could Change the AI Hardware Race
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
